The action of orotic acid as a positive inotropic agent during the acute phase of myocardial hypertrophy.
D000208:Acute Disease; D000818:Animals; D006332:Cardiomegaly / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D005492:Folic Acid / Q000494:pharmacology; D007930:Leucine / Q000378:metabolism; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism / Q000648:ultrastructure; D009963:Orotic Acid / Q000378:metabolism / Q000494:pharmacology*; D014176:Protein Biosynthesis; D051381:Rats; D013268:Stimulation, Chemical; D014529:Uridine / Q000494:pharmacology; D014805:Vitamin B 12 / Q000494:pharmacology
D009963:Orotic Acid; D005492:Folic Acid; D007930:Leucine; D014805:Vitamin B 12; D014529:Uridine